PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders

Post author:
Post published:May 22, 2024
Post category:uncategorized

PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKER™.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

TikTok can be a valuable tool for promoting cervical cancer screening

Engineered virus-like particles power up gene editing, correcting blindness in mice

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

Helpful Links

Subscribe To Us